Marksans Pharma gains on reporting 27% rise in Q3 consolidated net profit

12 Feb 2025 Evaluate

Marksans Pharma is currently trading at Rs 252.55, up by 1.10 points or 0.44% from its previous closing of Rs 251.45 on the BSE.

The scrip opened at Rs 252.05 and has touched a high and low of Rs 255.15 and Rs 239.25 respectively. So far 143344 shares were traded on the counter.

The BSE group 'A' stock of face value Rs 1 has touched a 52-week high of Rs 358.50 on 05-Dec-2024 and a 52-week low of Rs 126.05 on 14-Mar-2024.

Last one week high and low of the scrip stood at Rs 276.15 and Rs 239.25 respectively. The current market cap of the company is Rs 11290.57 crore.

The promoters holding in the company stood at 43.87%, while Institutions and Non-Institutions held 26.26% and 29.87% respectively.

The company has reported over two-fold jump in its net profit at Rs 55.46 crore for Q3FY25 as compared to Rs 25.29 crore for the same quarter in the previous year. Total income of the company increased by 37.78% at Rs 334.37 crore for Q3FY25 as compared to Rs 242.69 crore for the corresponding quarter previous year.

On consolidated basis, the company has reported 26.64% rise in its net profit at Rs 105.07 crore for the quarter ended December 31, 2024 as compared to Rs 82.97 crore for the same quarter in the previous year. Total income of the company increased by 20.10% at Rs 709.70 crore for Q3FY25 as compared to Rs 590.93 crore for the corresponding quarter previous year.

Marksans Pharma Share Price

183.95 -3.95 (-2.10%)
05-Dec-2025 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1804.95
Dr. Reddys Lab 1275.05
Cipla 1520.55
Zydus Lifesciences 931.45
Lupin 2097.65
View more..
Register Now to get our Free Newsletter & much more!

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×